Performance of the Abbott SARS-CoV-2 IgG II Quantitative Antibody Assay Including the New Variants of Concern, VOC 202012/V1 (United Kingdom) and VOC 202012/V2 (South Africa), and First Steps towards Global Harmonization of COVID-19 Antibody Methods

In the initial stages of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) COVID-19 pandemic, a plethora of new serology tests were developed and introduced to the global market. Many were not evaluated rigorously, and there is a significant lack of concordance in results across metho...

Descripción completa

Detalles Bibliográficos
Autores principales: English, Emma, Cook, Laura E., Piec, Isabelle, Dervisevic, Samir, Fraser, William D., John, W. Garry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Immunoassays
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373017/
https://www.ncbi.nlm.nih.gov/pubmed/34260272
http://dx.doi.org/10.1128/JCM.00288-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8373017/
https://www.ncbi.nlm.nih.gov/pubmed/34260272
http://dx.doi.org/10.1128/JCM.00288-21

Ejemplares similares